Results 171 to 180 of about 172,875 (307)

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

open access: yesAggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang   +6 more
wiley   +1 more source

Development and validation of a predictive model for in-hospital mortality in patients with coronary heart disease and renal insufficiency. [PDF]

open access: yesInt J Cardiol Cardiovasc Risk Prev
Li Y   +11 more
europepmc   +1 more source

PARATHYROID HYPERPLASIA IN RENAL INSUFFICIENCY [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1937
Tracy B. Mallory, Benjamin Castleman
openaire   +3 more sources

AIEgen‐Based and Smartphone‐Assisted On‐Site Quantitation of Cystatin C for Monitoring of Chronic Kidney Disease

open access: yesAggregate, EarlyView.
By employing new protein‐templated AIEgen Ir@BSA as the phosphorescence signal indicator and papain as the biomolecular recognition element, a straightforward protocol for Cys C quantitation has been developed. On‐site quantitation of Cys C in clinical serum samples has been successfully demonstrated using a smartphone‐based portable phosphorescence ...
Shuqi Xia   +7 more
wiley   +1 more source

Recurrent immunotactoid glomerulopathy in a kidney transplant recipient: Case report. [PDF]

open access: yesMedicine (Baltimore)
Yu S   +6 more
europepmc   +1 more source

Sickle Cell Diastolic Cardiomyopathy and Mortality Risk: A Novel Echocardiographic Framework for Prognostic Stratification

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Cardiovascular complications are the leading cause of mortality in sickle cell anemia (SCA) patients. While extensive data have identified diastolic dysfunction (DD) to increase morbidity and mortality, the unique hemodynamic conditions inherent to SCA challenge the current recommendations to assess diastolic function. Thus, there is an urgent
Théo Simon   +20 more
wiley   +1 more source

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo   +23 more
wiley   +1 more source

Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years. [PDF]

open access: yesEJHaem
Lee XH   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy